These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23987993)

  • 1. Human immunodeficiency virus, hepatitis C, and inflammatory biomarkers in individuals with alcohol problems: a cross-sectional study.
    Armah KA; Quinn EK; Cheng DM; Tracy RP; Baker JV; Samet JH; Freiberg MS
    BMC Infect Dis; 2013 Aug; 13():399. PubMed ID: 23987993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV Infection, HCV Coinfection, and Alcohol Use: Associations with Microbial Translocation and Immune Activation.
    Monnig MA; Cohen R; Ramratnam B; McAdams M; Tashima K; Monti PM
    Alcohol Clin Exp Res; 2019 Jun; 43(6):1126-1134. PubMed ID: 30908642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6 is associated with noninvasive markers of liver fibrosis in HIV-infected patients with alcohol problems.
    Fuster D; Tsui JI; Cheng DM; Quinn EK; Armah KA; Nunes D; Freiberg MS; Samet JH
    AIDS Res Hum Retroviruses; 2013 Aug; 29(8):1110-6. PubMed ID: 23601055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of hepatic fibrosis in HIV/HCV co-infected individuals in Yaoundé, Cameroon: usefulness of APRI score in resource-constrained settings.
    Dobseu R; Nanfack A; Kowo M; Ambada G; Kamgaing R; Chenwi C; Fainguem N; Ka'e A; Ngangoum E; Sosso S; Tchiegang C; Ndjolo A
    BMC Infect Dis; 2020 Oct; 20(1):758. PubMed ID: 33059627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. During Hepatitis C Virus (HCV) Infection and HCV-HIV Coinfection, an Elevated Plasma Level of Autotaxin Is Associated With Lysophosphatidic Acid and Markers of Immune Activation That Normalize During Interferon-Free HCV Therapy.
    Kostadinova L; Shive CL; Judge C; Zebrowski E; Compan A; Rife K; Hirsch A; Falck-Ytter Y; Schlatzer DM; Li X; Chance MR; Rodriguez B; Popkin DL; Anthony DD
    J Infect Dis; 2016 Nov; 214(9):1438-1448. PubMed ID: 27540113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of HIV infection and HCV viremia on inflammatory mediators and hepatic injury-The Women's Interagency HIV Study.
    Keating SM; Dodge JL; Norris PJ; Heitman J; Gange SJ; French AL; Glesby MJ; Edlin BR; Latham PS; Villacres MC; Greenblatt RM; Peters MG;
    PLoS One; 2017; 12(9):e0181004. PubMed ID: 28902848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV infection is associated with higher levels of monocyte chemoattractant protein-1 and eotaxin among people with recent hepatitis C virus infection.
    Lamoury FM; Hajarizadeh B; Keoshkerian E; Feld JJ; Amin J; Teutsch S; Matthews GV; Hellard M; Dore GJ; Lloyd AR; Applegate TL; Grebely J;
    BMC Infect Dis; 2016 Jun; 16():241. PubMed ID: 27246604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Inflammatory Biomarkers Associated with Advanced Liver Fibrosis in HIV-HCV-Coinfected Individuals.
    Chen X; Liu X; Duan S; Tang R; Zhou S; Ye R; Yang Y; Wang J; Yao S; He N
    Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33348839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage Activation and the Tumor Necrosis Factor Cascade in Hepatitis C Disease Progression Among HIV-Infected Women Participating in the Women's Interagency HIV Study.
    French AL; Martin JW; Evans CT; Peters M; Kessaye SG; Nowicki M; Kuniholm M; Golub E; Augenbraun M; Desai SN;
    J Acquir Immune Defic Syndr; 2017 Dec; 76(4):438-444. PubMed ID: 29077674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic Elevation of Proinflammatory Interleukin 18 in HIV/HCV Coinfection versus HIV or HCV Monoinfection.
    Veenhuis RT; Astemborski J; Chattergoon MA; Greenwood P; Jarosinski M; Moore RD; Mehta SH; Cox AL
    Clin Infect Dis; 2017 Mar; 64(5):589-596. PubMed ID: 27927859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection.
    Sacchi P; Cima S; Corbella M; Comolli G; Chiesa A; Baldanti F; Klersy C; Novati S; Mulatto P; Mariconti M; Bazzocchi C; Puoti M; Pagani L; Filice G; Bruno R
    Dig Liver Dis; 2015 Mar; 47(3):218-25. PubMed ID: 25544657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A matched cross-sectional study of the association between circulating tissue factor activity, immune activation and advanced liver fibrosis in hepatitis C infection.
    Hodowanec AC; Lee RD; Brady KE; Gao W; Kincaid S; Plants J; Bahk M; Mackman N; Landay AL; Huhn GD
    BMC Infect Dis; 2015 Apr; 15():190. PubMed ID: 25884329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of liver enzymes and inflammatory biomarkers for the severity of liver fibrosis stage in HIV/HCV co-infected patients.
    Charpentier C; Champenois K; Gervais A; Landman R; Joly V; Le Gac S; Larrouy L; Damond F; Brun-Vézinet F; Descamps D; Yazdanpanah Y
    PLoS One; 2013; 8(3):e59205. PubMed ID: 23527135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage inflammatory markers are associated with subclinical carotid artery disease in women with human immunodeficiency virus or hepatitis C virus infection.
    Shaked I; Hanna DB; Gleißner C; Marsh B; Plants J; Tracy D; Anastos K; Cohen M; Golub ET; Karim R; Lazar J; Prasad V; Tien PC; Young MA; Landay AL; Kaplan RC; Ley K
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1085-92. PubMed ID: 24651679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic fibrosis and immune phenotype vary by HCV viremia in HCV/HIV co-infected subjects: A Women's interagency HIV study.
    Desai SN; Dodge JL; Landay AL; Glesby MJ; Latham PS; Villacres MC; French AL; Gange SJ; Greenblatt RM; Peters MG
    Medicine (Baltimore); 2016 Aug; 95(33):e4483. PubMed ID: 27537569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of CD4⁺ T-cell immune activation and interleukin 10 levels among HIV, hepatitis C virus, and HIV/HCV-coinfected patients.
    Hodowanec AC; Brady KE; Gao W; Kincaid SL; Plants J; Bahk M; Landay AL; Huhn GD
    J Acquir Immune Defic Syndr; 2013 Nov; 64(3):232-40. PubMed ID: 24131865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers of inflammation, coagulation and microbial translocation in HIV/HCV co-infected patients in the SMART study.
    Peters L; Neuhaus J; Duprez D; Neaton JD; Tracy R; Klein MB; Mocroft A; Rockstroh J; Dore G; Lundgren JD;
    J Clin Virol; 2014 Jul; 60(3):295-300. PubMed ID: 24793968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Genetic Polymorphisms of Tumor Necrosis Factor Alpha and Interleukin 10 Genes on the Risk of Liver Cirrhosis in HIV-HCV Coinfected Patients.
    Corchado S; Márquez M; Montes de Oca M; Romero-Cores P; Fernández-Gutiérrez C; Girón-González JA
    PLoS One; 2013; 8(6):e66619. PubMed ID: 23840511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection.
    Mascia C; Lichtner M; Zuccalà P; Vita S; Tieghi T; Marocco R; Savinelli S; Rossi R; Iannetta M; Campagna M; Schiavone F; Mengoni F; Russo G; Mastroianni CM; Vullo V
    Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):644-655. PubMed ID: 28578937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of HIV infection and HIV/HCV coinfection with C-reactive protein levels: the fat redistribution and metabolic change in HIV infection (FRAM) study.
    Reingold J; Wanke C; Kotler D; Lewis C; Tracy R; Heymsfield S; Tien P; Bacchetti P; Scherzer R; Grunfeld C; Shlipak M
    J Acquir Immune Defic Syndr; 2008 Jun; 48(2):142-8. PubMed ID: 18344877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.